3SBio

3SBio is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative medicines. Founded in 1993, the company has built a broad portfolio of biologics and other therapies across oncology, autoimmune diseases, nephrology, metabolism, dermatology, and other therapeutic areas, with a particular strength in recombinant proteins and antibody-based medicines.

3SBio operates an integrated platform spanning drug discovery, preclinical and clinical development, manufacturing, and commercialization, supported by R&D centers and production facilities in China and internationally. The company is also expanding its global reach through overseas product registrations, clinical development, and partnerships with international pharmaceutical companies, including licensing collaborations for medicines developed through its own research platform.